Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases

Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases

Bibliographic Details
Main Authors:	Menachem Z. Yondorf, Shahdabul Faraz, Andrew Smith, Albert Sabbas, Bhupesh Parashar, Theodore Schwartz, A. Gabriella Wernicke
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-08-01
Series:	Journal of Contemporary Brachytherapy
Subjects:	cesium-131 (<sup>131</sup>cs) iodine-125 (<sup>125</sup>i) brachytherapy metastases recurrence radiation necrosis
Online Access:	https://www.termedia.pl/Dosimetric-differences-between-cesium-131-and-iodine-125-brachytherapy-for-the-treatment-of-resected-brain-metastases,54,41561,1,1.html

Similar Items

Placement of 131 Cs permanent brachytherapy seeds in a large combined cavity of two resected brain metastases in one setting: case report and technical note
by: Jacelyn Greenwald, et al.
Published: (2019-08-01)

A Thermal Sublimation Generator of <sup>131m</sup>Xe
by: Karolina Kulesz, et al.
Published: (2022-11-01)

Computed tomography-guided implantation of 125 I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results
by: Jie Li, et al.
Published: (2017-04-01)

Cesium-131 Interstitial Brachytherapy for Recurrent Malignancies of Skull Base
by: Corey Savard, et al.
Published: (2019-04-01)

Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma
by: Chao-Cheng Chen, et al.
Published: (2020-09-01)

Dose Distribution of High Dose-Rate and Low Dose-Rate Prostate Brachytherapy at Different Intervals—Impact of a Hydrogel Spacer and Prostate Volume
by: Hathal Haddad, et al.
Published: (2023-02-01)

Radiosynthesis, Stability, Lipophilicity, and Cellular Uptake Evaluations of [<sup>131</sup>I]Iodine-α-Mangostin for Breast Cancer Diagnosis and Therapy
by: Wiwit Nurhidayah, et al.
Published: (2023-05-01)

The Diagnostic Usefulness of <sup>131</sup>I-SPECT/CT at Both Radioiodine Ablation and during Long-Term Follow-Up in Patients Thyroidectomized for Differentiated Thyroid Carcinoma: Analysis of Tissue Risk Factors Ascertained at Surgery and Correlated with Metastasis Appearance
by: Angela Spanu, et al.
Published: (2021-08-01)

Pathological impairments induced by interstitial implantation of <sup>125</sup>I Seeds in spinal canal of banna mini-pigs
by: Yang Zuozhang, et al.
Published: (2012-03-01)

Comparative cost-effectiveness of focal and total salvage 125 I brachytherapy for recurrent prostate cancer after primary radiotherapy
by: Max Peters, et al.
Published: (2016-12-01)

Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot Study
by: Michael Kharouta, et al.
Published: (2021-03-01)

Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer’s Disease Brain by Autoradiography Using [<sup>18</sup>F]Flotaza, [<sup>125</sup>I]IBETA, [<sup>124/125</sup>I]IPPI and Immunohistochemistry Analysis Using QuPath
by: Rommani Mondal, et al.
Published: (2023-03-01)

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
by: Adam Luginbuhl, et al.
Published: (2021-11-01)

Computed tomography-guided implantation of 125I radioactive seeds in patients with malignant airway compression induced by advanced lung cancer: effectiveness and safety in 40 patients
by: Zhiyou Zhao, et al.
Published: (2020-08-01)

Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via <sup>18</sup>F-Sodium Fluoride PET/CT Imaging
by: Carmela Nappi, et al.
Published: (2024-01-01)

[<sup>125</sup>I]INFT: Synthesis and Evaluation of a New Imaging Agent for Tau Protein in Post-Mortem Human Alzheimer’s Disease Brain
by: Roz R. Limpengco, et al.
Published: (2023-07-01)

Delivery of the Radionuclide <sup>131</sup>I Using Cationic Fusogenic Liposomes as Nanocarriers
by: Rejhana Kolašinac, et al.
Published: (2021-01-01)

Dissolved Radiotracers and Numerical Modeling in North European Continental Shelf Dispersion Studies (1982–2016): Databases, Methods and Applications
by: Pascal Bailly du Bois, et al.
Published: (2020-06-01)

Advances in Antioxidant Applications for Combating <sup>131</sup>I Side Effects in Thyroid Cancer Treatment
by: Li Yang, et al.
Published: (2023-06-01)

Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen<sup>®</sup>, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease
by: Ana Claudia R. Durante, et al.
Published: (2019-02-01)

Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter
by: Kazuko Kaneda-Nakashima, et al.
Published: (2022-12-01)

Inhibition of HIF-1α by Atorvastatin During <sup>131</sup>I-RTX Therapy in Burkitt’s Lymphoma Model
by: Eun-Ho Kim, et al.
Published: (2020-05-01)

Improved Quantification of <sup>18</sup>F-FDG PET during <sup>131</sup>I-Rituximab Therapy on Mouse Lymphoma Models after <sup>131</sup>I Prompt Emission Correction
by: Young Sub Lee, et al.
Published: (2019-10-01)

Genotoxicity Associated with <sup>131</sup>I and <sup>99m</sup>Tc Exposure in Nuclear Medicine Staff: A Physical and Biological Monitoring Study
by: Justyna Miszczyk, et al.
Published: (2022-05-01)

Changes in lower urinary tract symptoms after prostate brachytherapy
by: Bruce L. Jacobs, et al.
Published: (2011-09-01)

Comparison of the Therapeutic Effects of [<sup>211</sup>At]NaAt and [<sup>131</sup>I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model
by: Tadashi Watabe, et al.
Published: (2022-08-01)

Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
by: Michele Klain, et al.
Published: (2021-08-01)

Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer
by: Xiaodong Huo, et al.
Published: (2017-12-01)

Carotid dosimetry after re-irradiation with 131Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
by: Amanda Walsh, et al.
Published: (2019-06-01)

Single institution implementation of permanent 131Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma
by: Voichita Bar-Ad, et al.
Published: (2019-06-01)

The effectiveness and prognostic factors of radioactive iodine-125 seed implantation for the treatment of cervical lymph node recurrence of esophageal squamous cell carcinoma after external beam radiation therapy
by: Yuwei Zhang, et al.
Published: (2020-12-01)

A Preclinical Study of an <sup>125</sup>I-Labeled PSMA Ligand for Prostate-Cancer Puncture
by: Xiaohui Luan, et al.
Published: (2022-10-01)

Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
by: Hiroshi Wakabayashi, et al.
Published: (2020-09-01)

RADIOIODINE TREATMENT OF GRAVES’ DISEASE – DOSE/RESPONSE ANALYSIS
by: Jitka Čepková, et al.
Published: (2014-01-01)

Synthesis and Evaluation of Compound Targeting α7 and β2 Subunits in Nicotinic Acetylcholinergic Receptor
by: Karanveer Singh, et al.
Published: (2023-12-01)

TNF-α May Exert Different Antitumor Effects in Response to Radioactive Iodine Therapy in Papillary Thyroid Cancer with/without Autoimmune Thyroiditis
by: Dan Cristian Gheorghe, et al.
Published: (2021-07-01)

Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
by: David Kersting, et al.
Published: (2021-04-01)

Verification and uniformity control of doses for <sup> 90</sup> Sr/<sup> 90</sup> Y intravascular brachytherapy sources using radiochromic film dosimetry
by: Demir Bayram, et al.
Published: (2008-01-01)

Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain
by: Amina U. Syed, et al.
Published: (2023-06-01)

Characterization of Sigma-2 Receptor—Specific Binding Sites Using [<sup>3</sup>H]DTG and [<sup>125</sup>I]RHM-4
by: Chi-Chang Weng, et al.
Published: (2022-12-01)